• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Outpatient led intervention did not decrease heavy drinking at one year

byShayna BejaimalandAnees Daud
March 28, 2018
in Chronic Disease, Gastroenterology, Public Health
Reading Time: 2 mins read
Factors contributing to parents providing alcohol sips to adolescents
Share on FacebookShare on TwitterShare on LinkedIn

1. In this randomized controlled trial, there was no significant difference between the CHOICE intervention (intervention led by nurse care managers) and usual care in decreasing heavy drinking and alcohol-related symptoms in outpatients that reported heavy drinking at baseline.

2. Participants in the intervention group received more alcohol-related care including alcohol-use disorder (AUD) medications.

Evidence Rating Level: 2 (Good)

Study Rundown: Alcohol use disorder (AUD) that is a public health issue where less than 20% of those with AUDs receive treatment. It is thought that management of AUD can be done in primary care however the most effective treatment plan is unknown. This randomized controlled trial aimed to test whether 12 months of alcohol care management led by nurse care managers, compared with usual care, improved drinking outcomes among patients with or at high risk of AUDs.

Despite having increased alcohol-related care (AUD medication use, motivational interviewing and shared decision making) participants in the CHOICE intervention did not have a significant difference as compared to usual care with regards to percentage of heavy drinking in the prior 28 days and no alcohol-related symptoms in the past 3 months. This was non-significant at both 3 months and 12 months post-intervention. Limitations of this study included use of multistep recruitment that may have motivated patients receiving usual care to change or seek care perhaps biasing towards the null.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

No Content Available

Relevant Reading: Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence The COMBINE Study: A Randomized Controlled Trial

In-Depth [randomized controlled trial]: This randomized trial was conducted at three Veterans Affairs (VA) primary care clinics between October 2011 and September 2014, and included 304 participants. Participants were adults who reported heavy drinking (≥ 4 drinks per day for women or ≥5 drinks per day for men). Exclusion criteria included those with acute medical or psychiatric instability, alcohol treatment in the previous 90 days, cognitive impairment, end-of-life care, current or planned pregnancy and those leaving or planning to leave the VA system. Patients were randomized 1:1 to usual VA primary care or usual care with Choosing Healthier Drinking Options in Primary Care (CHOICE) intervention (AUD medication administration, motivational interviewing). The primary outcome, which was assessed by blinded telephone interviewers at 12-months, was the percentage of heavy drinking days in the prior month and no alcohol-related symptoms in the past 3 months. Intention-to-treat analysis was used.

Of the 304 participants, 90% were male and the mean age was 51.4 years. One hundred fifty were randomized to the CHOICE intervention and 154 to usual care. Both groups reported heavy drinking on 61% of days (95% CI 56%-66%). The intervention group had nursing visits and received more alcohol-related care and AUD medication than the usual care group. Despite this, at 12 months, there were no significant differences in the primary outcome between both groups (P=0.32 to 0.44).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alcoholism
Previous Post

2 Minute Medicine Rewind March 26, 2018

Next Post

Isolated vomiting not linked to clinically important TBI in children

RelatedReports

No Content Available
Next Post
Computed tomography improves diagnostic certainty in the emergency department

Isolated vomiting not linked to clinically important TBI in children

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

Venetoclax plus rituximab increases progression-free survival in relapsed chronic lymphocytic leukemia

Parental immunization status associated with likelihood of vaccinating children

Quadrivalent recombinant influenza vaccine noninferior to inactivated vaccine

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.